BIT Capital’s Procept Biorobotics PRCT Stock Holding History

BIT Capital’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-17,025	Closed	-$1.04M	–	131
2024 Q2	$1.04M	Buy	+17,025	New	+$1.01M	0.08%	77

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BIT Capital's PRCT Position: Q3 2024 in Review

BIT Capital sold out of Procept Biorobotics (PRCT) in Q3 2024, closing a stake of 17,025 shares — an estimated $1.04M sold.

BIT Capital first reported a position in PRCT in Q2 2024 and held it in 1 quarter. The position peaked at $1.04M in Q2 2024. 250 funds tracked by Wall St. Rank hold PRCT as of Q3 2024.

BIT Capital reported no remaining Procept Biorobotics position as of Q3 2024 after selling out during the quarter.
BIT Capital sold 17,025 Procept Biorobotics shares in Q3 2024, an estimated $1.04M.
BIT Capital first reported a position in Procept Biorobotics in Q2 2024 and held it in 1 quarter.
BIT Capital's Procept Biorobotics position peaked at $1.04M in Q2 2024.
250 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2024.

Based on BIT Capital's 13F filing for Q3 2024, filed 12 Feb 2025.